Xenon Pharmaceuticals Inc. XENE
CIK 0001582313
Form 4 transactions dated Sep 1, 2023 to Sep 23, 2026, as reported to the SEC.
Insider purchases & sales
- Purchased
- $0.00
- Sold
- $27.50M
Sep 1, 2023 – Sep 3, 2026
Available records · partial months are marked ·
| Date | Insider | Activity | Trade value (USD) | % of prior holding | |
|---|---|---|---|---|---|
| 2026-08-28 | KENNEY CHRISTOPHER JOHN Chief Medical Officer | Sale10b5-1 footnote | $425.83K 7,068 shares sold | 99.97% sold Direct holding | ▾ |
| 2026-08-11 | GANNON STEVEN Director | Sale | $640.55K 10,000 shares sold | 84.25% sold Direct holding | ▾ |
| 2026-06-05 | PATOU GARY Director | Sale10b5-1 footnote | $70.25K 1,322 shares sold | 5.04% sold Direct holding | ▾ |
| 2026-06-05 | Cannon Gillian Director | Sale10b5-1 footnote | $63.24K 1,190 shares sold | 44.99% sold Direct holding | ▾ |
| 2026-03-13 | KENNEY CHRISTOPHER JOHN Chief Medical Officer | Sale10b5-1 footnote | $77.87K 1,410 shares sold | 16.63% sold Direct holding | ▾ |
| 2026-03-13 | DiFabio Andrea Chief Legal Officer | Sale10b5-1 footnote | $74.11K 1,342 shares sold | 15.53% sold Direct holding | ▾ |
| 2026-03-13 | MORTIMER IAN PRESIDENT & CEO · Director | Sale10b5-1 footnote | $403.58K 7,308 shares sold | 26.84% sold Direct holding | ▾ |
| 2026-03-10 | KENNEY CHRISTOPHER JOHN Chief Medical Officer | Sale10b5-1 footnote | $166.56K 2,771 shares sold | 36.95% sold Direct holding | ▾ |
| 2026-03-10 | DiFabio Andrea Chief Legal Officer | Sale10b5-1 footnote | $156.70K 2,607 shares sold | 34.76% sold Direct holding | ▾ |
| 2026-03-10 | MORTIMER IAN PRESIDENT & CEO · Director | Sale10b5-1 footnote | $677.36K 11,269 shares sold | 43.34% sold Direct holding | ▾ |
Showing 12 / 12 record groups in 2026. The complete set is available through the API.
Follow the people behind the trades.
Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and reach other datasets through the Akkru API.
- Download CSV
- Earlier filings
- Advanced screening & filtering
- API & AI access
＋ New accounts get free API credits to explore data beyond ownership filings.
For AI agents & developers
The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. For the year shown, this page lists 12 of 12 purchase / sale groups and 30 of 63 other groups; the totals and the monthly series cover the whole window.
Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.
MCP https://api.akkrudata.ai/mcp
list_insider_transactions
{"ticker":"XENE","transaction_code":["P","S"],"transaction_form_type":"4","page_size":20}Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.
- MCP endpoint
- https://api.akkrudata.ai/mcp
- API / MCP documentation
- /documents
- llms.txt
- /llms.txt
Sources, coverage & how to read this data
Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.